Strategy for preventing peritoneal dialysis failure.
Cancarini
G
G
University of Brescia and Division of Nephrology, Spedali Civili, Brescia, Italy. Giovanni.C.Cancarini@numerica.it
D000596:Amino Acids / Q000737:chemistry; D015314:Dialysis Solutions / Q000009:adverse effects / Q000494:pharmacology; D004349:Drug Packaging; D004866:Equipment Contamination; D004867:Equipment Design; D005936:Glucans / Q000737:chemistry; D005947:Glucose / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D017127:Glycation End Products, Advanced / Q000009:adverse effects; D005990:Glycerol / Q000737:chemistry; D006801:Humans; D006982:Hypertonic Solutions / Q000009:adverse effects; D000077607:Icodextrin; D009997:Osmotic Pressure; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000379:methods; D010537:Peritoneum / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010538:Peritonitis / Q000209:etiology / Q000517:prevention & control; D010539:Permeability; D011312:Pressure; D017211:Treatment Failure
D000596:Amino Acids; D015314:Dialysis Solutions; D005936:Glucans; D017127:Glycation End Products, Advanced; D006982:Hypertonic Solutions; D000077607:Icodextrin; D005947:Glucose; D005990:Glycerol